PCN80 BUDGET IMPACT IN THE USA OF LIPOSOMAL IRINOTECAN AS A POST-GEMCITABINE TREATMENT OPTION FOR PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA (MPC)
Herrera-Restrepo, O., Ferrufino, C., Bilir, S.P., Cockrum, P., Valderrama, A.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.204
Date:
May, 2019
File:
PDF, 381 KB
english, 2019
File converter
More search results
More benefits 
